4. At number 4 on our list of health benefits of medical marijuana according to publicly traded companies we have this quote:”The results of this trial substantiate data from our single-ascending dose trial of APD371. In both trials, we achieved dose-responsive exposure without dose-limiting adverse events across the range studied. Our scientists designed APD371 as a highly selective, peripherally restricted, full agonist to provide pain relief without psychotropic effects, loss of efficacy over time, or the dependence, abuse potential or adverse event profile associated with other pain treatments.” – William R. Shanahan, Jr., M.D., Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)’s Senior Vice President and Chief Medical Officer.
Follow Arena Pharmaceuticals Inc (NASDAQ:ARNA)
Follow Arena Pharmaceuticals Inc (NASDAQ:ARNA)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.